RIL shareholders approved resolutions on Aug 20, 2026. Caplin Point, NATCO Pharma, and Choksi Labs received US FDA Form 483 observations. Mobile & EMS…
1/9Reliance Industries | RIL said shareholders approved three resolutions with the requisite majority on August 20, 2026. The resolutions include proposals covering material related-party transactions of RIL and its subsidiaries, along with an expansion of the company’s objects clause to include the production, processing, sale and distribution of ammonium nitrate, explosives, blasting agents, fertilisers and agro-chemicals.
2/9Caplin Point Laboratories | The firm said the US FDA issued a Form 483 with 10 observations after concluding an unannounced inspection at one of the company’s manufacturing units. The inspection was conducted from August 13 to 21, 2026.
3/9NATCO Pharma | The company said the US FDA issued a Form 483 with four observations after concluding an inspection at the company’s finished dosage formulations (FDF) unit in Hyderabad. The inspection was conducted from August 17 to 21, 2026.
4/9Choksi Laboratories | The labs firm said the US FDA concluded an inspection at its central laboratory in Indore, Madhya Pradesh, conducted from August 17 to 20, 2026. The inspection resulted in four observations.
5/9Mobile & EMS stocks: Dixon Technologies, Optiemus Infracom, Kaynes Technology, Syrma SGS Technology, Avalon Technologies and Cyient DLM could be in focus after the government notified the Mobile Phone Manufacturing Scheme 2.0.
6/9POWERGRID | State-owned Power Grid Corporation of India Ltd said it has been declared the successful bidder under Tariff Based Competitive Bidding (TBCB) to establish an inter-state transmission system for renewable energy projects in Gujarat at a discovered tariff of ₹822.91 crore per annum.
7/9Apollo Micro Systems Ltd | Leading technology-driven firm in the aerospace, defence, and homeland security sectors said that its Manager to the Open Offer has received a letter from the Securities and Exchange Board of India (SEBI) regarding the company’s proposed open offer for the acquisition of up to 1.40 crore fully paid-up equity shares of Premier Explosives Ltd.
8/9Federal Bank Ltd | Kerala-based private lender said its board has approved a proposal to raise funds through the issuance of foreign currency-denominated bonds for an aggregate amount of up to $500 million through its IFSC Banking Unit (IBU) in GIFT City.
9/9Jubilant Pharmova | The Noida-headquartered pharmaceutical firm received USFDA approval for commercial batch manufacturing of the first product on Line 3, a new isolator-based fill-and-finish line at its Spokane, Washington facility. The facility is operated by Jubilant HollisterStier LLC, a subsidiary of Jubilant Pharmova’s wholly owned subsidiary Jubilant Pharma Limited.
